About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Not Yet RecruitingNA

fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations

Treat Refractory Auditory Hallucinations in Schizophrenia Patients With fMRI-guided Neurofeedback: a Randomized-controlled Trial

NCT04798131•University Hospital, Lille

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

SchizophreniaHallucinations, AuditoryHallucinations, Visual

Interventions

Active neurofeedback procedure

Sham neurofeedback procedure

Key Dates

Start Date

December 1, 2022

Primary Completion Date

July 1, 2026

Completion Date

July 1, 2026

Last Updated

March 25, 2022

Related Studies

RECRUITINGPhase 3

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

NCT06894212

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

NCT06003036

SchizophreniaSchizoaffective Disorder

RECRUITINGPhase 2

Synbiotic Compound to Reduce Symptoms of Schizophrenia

NCT04226898

SchizophreniaSchizoaffective Disorder

RECRUITINGPhase 2

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

NCT05240976

Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study

NCT06745479

SchizophreniaSchizoaffective Disorder+1 more

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

NCT07455929

Psychotic DisordersSchizophrenia Spectrum Disorders

View all related studies

Contacts

Renaud JARDRI, MD,PhD

CONTACT

0320445962 renaud.jardri@chru-lille.fr

Sponsors

Lead Sponsor

University Hospital, Lille

Collaborators

National Research Agency, France

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 25, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions